Current situation of medication adherence in hypertension

Frontiers in Pharmacology

Volumn 8, Issue MAR, 2017, Pages

  Vrijens, Bernard ^a,b   Antoniou, Sotiris ^c   Burnier, Michel ^d   de la Sierra, Alejandro ^e   Volpe, Massimo ^f,g  

^a Westrock Healthcare   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF BARCELONA   (Spain)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g IRCCS NEUROMED   (Italy)

Author keywords

Adherence; Antihypertensive; Implementation; Initiation; Medication; Persistence

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ACCURACY; AWARENESS; BLOOD PRESSURE; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL PRACTICE; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; HYPERTENSION; MONITORING; PATIENT COMPLIANCE; REVIEW;

EID: 85016157719     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00100     Document Type: Review

References (42)

1. Barber, N., Parsons, J., Clifford, S., Darracott, R., and Horne, R. (2004). Patients' problems with new medication for chronic conditions. Qual. Saf. Health Care 13, 172-175. doi: 10.1136/qshc.2003.005926
2. Belknap, R., Weis, S., Brookens, A., Au-Yeung, K. Y., Moon, G., DiCarlo, L., et al. (2013). Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy. PLoS ONE 8:e53373. doi: 10.1371/journal.pone.0053373
3. Blaschke, T. F., Osterberg, L., Vrijens, B., and Urquhart, J. (2012). Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu. Rev. Pharmacol. Toxicol. 52, 275-301. doi: 10.1146/annurev-pharmtox-011711-113247
4. Brinker, S., Pandey, A., Ayers, C., Price, A., Raheja, P., Arbique, D., et al. (2014). Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J. Am. Coll. Cardiol. 63, 834-835. doi: 10.1016/j.jacc.2013.10.067
5. Burnier, M., Brown, R. E., Ong, S. H., Keskinaslan, A., and Khan, Z. M. (2009). Issues in blood pressure control and the potential role of single-pill combination therapies. Int. J. Clin. Pract. 63, 790-798. doi: 10.1111/j.1742-1241.2009.01999.x
6. Burnier, M., Schneider, M. P., Chioléro, A., Stubi, C. L., and Brunner, H. R. (2001). Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J. Hypertens. 19, 335-341. doi: 10.1097/00004872-200102000-00022
7. Choudhry, N. K., Denberg, T. D., Qaseem, A., and Clinical Guidelines Committee of American College of Physicians (2016). Improving adherence to therapy and clinical outcomes while containing costs: opportunities from the greater use of generic medications: best practice advice from the clinical guidelines committee of the american college of physicians. Ann. Intern. Med. 164, 41-49. doi: 10.7326/M14-2427
8. Corrao, G., Parodi, A., Nicotra, F., Zambon, A., Merlino, L., Cesana, G., et al. (2011). Better compliance to antihypertensive medications reduces cardiovascular risk. J. Hypertens. 29, 610-618. doi: 10.1097/HJH.0b013e328342ca97
9. Dupclay, L., Eaddy, M., Jackson, J., Raju, A., and Shim, A. (2012). Real-world impact of reminder packaging on antihypertensive treatment adherence and persistence. Patient Prefer. Adherence 6, 499-507. doi: 10.2147/PPA.S31417
10. EFPIA (2013). Health & Growth-Evidence Compendium. Available at: http://www.efpia.eu/uploads/Modules/Documents/health-and-growth_evidence-compendium.pdf Retrieved [accessed 21 October, 2016]
11. Fischer, M. A., Stedman, M. R., Lii, J., Vogeli, C., Shrank, W. H., Brookhart, M. A., et al. (2010). Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J. Gen. Intern. Med. 25, 284-290. doi: 10.1007/s11606-010-1253-9
12. Gerbino, P. P., and Shoheiber, O. (2007). Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am. J. Health Syst. Pharm. 64, 1279-1283. doi: 10.2146/ajhp060434
13. Glynn, L. G., Murphy, A. W., Smith, S. M., Schroeder, K., and Fahey, T. (2010). Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst. Rev. 3:CD005182. doi: 10.1002/14651858.CD005182.pub4
14. Gupta, A. K., Arshad, S., and Poulter, N. R. (2010). Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 55, 399-407. doi: 10.1161/HYPERTENSIONAHA.109.139816
15. Health Social Care Information Centre (2015). Health Survey for England. Available at: http://content.digital.nhs.uk/catalogue/PUB19297
16. Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H. C., Hacke, W., et al. (2015). Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17, 1467-1507. doi: 10.1093/europace/euv309
17. IMS (2012). Responsible Use of Medicines Report. Available at: http://www.imshealth.com/en/thought-leadership/ims-institute/reports/responsible-use-of-medicines-report#ims-form
18. Iuga, A. O., and McGuire, M. J. (2014). Adherence and health care costs. Risk Manag. Healthc. Policy 7, 35-44. doi: 10.2147/RMHP.S19801
19. Jung, O., Gechter, J. L., Wunder, C., Paulke, A., Bartel, C., Geiger, H., et al. (2013). Resistant hypertension? Assessment of adherence by toxicological urine analysis. J. Hypertens. 31, 766-774. doi: 10.1097/HJH.0b013e32835e2286
20. Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., et al. (2013). 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC). Eur. Heart J. 34, 2159-2219. doi: 10.1093/eurheartj/eht151
21. Meddings, J., Kerr, E. A., Heisler, M., and Hofer, T. P. (2012). Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss. BMC Health Serv. Res. 12:270. doi: 10.1186/1472-6963-12-270
22. Mennini, F. S., Marcellusi, A., von der Schulenburg, J. M., Gray, A., Levy, P., Sciattella, P., et al. (2015). Cost of poor adherence to anti-hypertensive therapy in five European countries. Eur. J. Health Econ. 16, 65-72. doi: 10.1007/s10198-013-0554-4
23. NICE (2009). Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence (CG76). Clinical guidelines. Available at: https://www.nice.org.uk/guidance/cg76/resources/medicines-adherence-involving-patients-in-decisions-about-prescribed-medicines-and-supporting-adherence-975631782085 [accessed 15 September, 2016].
24. Nielsen, J. O., Shrestha, A. D., Neupane, D., and Kallestrup, P. (2017). Non-adherence to anti-hypertensive medication in low-and middle-income countries: a systematic review and meta-analysis of 92443 subjects. J. Hum. Hypertens. 31, 14-21. doi: 10.1038/jhh.2016.31
25. Osterberg, L. G., Urquhart, J., and Blaschke, T. F. (2010). Understanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeutics. Clin. Pharmacol. Ther. 88, 457-459. doi: 10.1038/clpt.2010.171
26. PriceWaterhouseCoopers (2007). Pharma 2020: Supplying the Future. Which Path will you take?. Available at: https://www.pwc.com/gx/en/pharma-life-sciences/pdf/pharma-2020-supplying-the-future.pdf [accessed 15 September, 2016].
27. Redon, J., Brunner, H. R., Ferri, C., Hilgers, K. F., Kolloch, R., and van Montfrans, G. (2008). Practical solutions to the challenges of uncontrolled hypertension: a white paper. J. Hypertens. Suppl. 26, S1-S14. doi: 10.1097/01.hjh.0000343507.74401.45
28. Sherrill, B., Halpern, M., Khan, S., Zhang, J., and Panjabi, S. (2011). Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J. Clin. Hypertens. 13, 898-909. doi: 10.1111/j.1751-7176.2011.00550.x
29. Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., et al. (2006). A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 333, 15. doi: 10.1136/bmj.38875.675486.55
30. Volpe, M., Ambrosioni, E., Borghi, C., Cottone, S., Cuspidi, C., De Luca, N., et al. (2012a). [Strategies for improving blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 2012 Position paper of the Italian Society of Hypertension]. G. Ital. Cardiol. 13, 853-860. doi: 10.1714/1188.13170
31. Volpe, M., Ambrosioni, E., Borghi, C., Cottone, S., Cuspidi, C., De Luca, N., et al. (2012b). Strategie per migliorare il controllo della pressione arteriosa in Italia: dalla stratificazione del rischio cardiovascolare globale alla terapia di combinazione. Ipertensione Prev. Cardiovasc. 19, 187-196.
32. Volpe, M., de la Sierra, A., Kreutz, R., Laurent, S., and Manolis, A. J. (2014). ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients. High Blood Press Cardiovasc. Prev. 21, 137-147. doi: 10.1007/s40292-014-0043-6
33. Volpe, M., Rosei, E. A., Ambrosioni, E., Cottone, S., Cuspidi, C., Borghi, C., et al. (2013). 2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. High Blood Press Cardiovasc. Prev. 20, 45-52. doi: 10.1007/s40292-013-0007-2
34. Vrijens, B. (ed.). (2016). An Introduction to Adherence Research. Drug Utilization Research: Methods and Applications. New York, NY: John Wiley & Sons, Ltd.
35. Vrijens, B., Belmans, A., Matthys, K., de Klerk, E., and Lesaffre, E. (2006). Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. Pharmacoepidemiol. Drug Saf. 15, 115-121. doi: 10.1002/pds.1198
36. Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., et al. (2012). A new taxonomy for describing and defining adherence to medications. Br. J. Clin. Pharmacol. 73, 691-705. doi: 10.1111/j.1365-2125.2012.04167.x
37. Vrijens, B., and Heidbuchel, H. (2015). Non-vitamin K antagonist oral anticoagulants: considerations on once-vs. twice-daily regimens and their potential impact on medication adherence. Europace 17, 514-523. doi: 10.1093/europace/euu311
38. Vrijens, B., and Urquhart, J. (2014). Methods for measuring, enhancing, and accounting for medication adherence in clinical trials. Clin. Pharmacol. Ther. 95, 617-626. doi: 10.1038/clpt.2014.59
39. Vrijens, B., Urquhart, J., and White, D. (2014). Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence. Expert Rev. Clin. Pharmacol. 7, 633-644. doi: 10.1586/17512433.2014.940896
40. Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J., and Burnier, M. (2008). Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 336, 1114-1117. doi: 10.1136/bmj.39553.670231.25
41. World Health Organization [WHO] (2003). Adherence to Long-Term Therapies. Evidence for Action. Available at: http://www.who.int/chp/knowledge/publications/adherence:full_report.pdf [accessed 14 September, 2016].
42. York Health Economics Consortium, The School of Pharmacy, University of London (2010). Evaluation of the Scale, Cause and Costs of Waste Medicines. Final Report. Available at: https://core.ac.uk/download/pdf/111804.pdf?repositoryId=90 [accessed 15 September, 2016].